Semble Raises £30M to Expand Healthcare Platform

The big picture: Semble, a UK-based clinical platform, has raised £30 million in a Series C funding round led by European growth investor Revaia. The company aims to address the fragmentation in healthcare software by connecting scheduling, clinical records, billing, diagnostics, and patient communications within a single platform.

Why it matters:

• Fragmented Systems: Healthcare providers often operate across a patchwork of disconnected software tools, leading to significant administrative burden and reduced time for patient care.
• Growing Market Pressure: The UK private healthcare market is experiencing record growth, increasing the demand for efficient, integrated solutions to manage rising patient admissions and operational complexity.
• AI Integration Layer: Semble is positioning itself as a crucial infrastructure layer for future AI tools in healthcare, enabling clinicians to access advanced capabilities like clinical decision support and real-time care coordination.

How it works:

• Integration-First Approach: Semble’s platform integrates with over 1,200 external tools, including diagnostics, billing, and customer management systems, allowing healthcare groups to connect existing solutions without a complete overhaul.
• Comprehensive Clinical Operations: The platform covers the full spectrum of day-to-day outpatient care, from scheduling and electronic health records to telehealth consultations, payments, and patient communications.
• Open Architecture: Designed for flexibility, Semble’s open system connects with various tools, making it adaptable for clients ranging from solo practitioners to large hospital groups across 80 medical specialities.

The catch: While Semble’s integration-focused approach aims to ease adoption, convincing deeply entrenched healthcare organizations to shift their core operational workflows to a new orchestration layer remains a significant challenge. The market for integrated healthcare platforms is competitive, with both established enterprise solutions and emerging AI-native tools vying for provider attention. Sustaining rapid expansion into new, complex regulatory environments like France will also test the platform’s adaptability and market penetration strategy.